腫瘤異質性 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "腫瘤異質性" in Chinese language version.
refsWebsite
Global rank
Chinese rank
18th place
57th place
11th place
332nd place
6th place
4th place
1st place
1st place
120th place
337th place
low place
low place
low place
low place
5th place
12th place
archive.org
- Heppner, G.A. Tumor Heterogeneity. Cancer Research. 1984, 44 (6): 2259–2265. PMID 6372991.
- Konishi, N; Hiasa, Y; Matsuda, H; Tao, M; Tsuzuki, T; Hayashi, I; Kitahori, Y; Shiraishi, T; Yatani, R; Shimazaki, J. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. The American Journal of Pathology. 1995, 147 (4): 1112–1122. PMC 1871010
. PMID 7573356. - Giaretti, W; Monaco, R; Pujic, N; Rapallo, A; Nigro, S; Geido, E. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: Association with degree of DNA aneuploidy. The American Journal of Pathology. 1996, 149 (1): 237–245. PMC 1865212 . PMID 8686748.
- Heppner, G. H. Tumor heterogeneity. Cancer Research. 1984, 44 (6): 2259–2265. PMID 6372991.
- G.M.Edelman. Topobiology. Scientific American. 1989, 260 (5): 76–88. Bibcode:1989SciAm.260e..76E. PMID 2717916. doi:10.1038/scientificamerican0589-76.
doi.org
- Marusyk, A; Polyak, K. Tumor heterogeneity: Causes and consequences. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2010, 1805 (1): 105–117. PMC 2814927 . PMID 19931353. doi:10.1016/j.bbcan.2009.11.002.
- Vogelstein, Bert; Papadopoulos, N.; Velculescu, V.E.; Zhou, S.; Diaz, L.A.; Kinzler, K.W. Cancer Genome Landscapes. Science. 2013, 373 (6127): 1546–1556. Bibcode:2013Sci...339.1546V. PMC 3749880 . PMID 23539594. doi:10.1126/science.1235122.
- Reiter, Johannes G; Makohon-Moore, Alvin P; Gerold, Jeffrey M; Heyde, Alexander; Attiyeh, Marc A; Kohutek, Zachary A; Tokheim, Collin J; Brown, Alexia; DeBlasio, Rayne; Niyazov, Juliana; Zucker, Amanda. Minimal functional driver gene heterogeneity among untreated metastases. Science. 2018, 361 (6406): 1033–1037. Bibcode:2018Sci...361.1033R. PMC 6329287 . PMID 30190408. doi:10.1126/science.aat7171.
- Campbell, P. J.; Pleasance, E. D.; Stephens, P. J.; Dicks, E; Rance, R; Goodhead, I; Follows, G. A.; Green, A. R.; Futreal, P. A.; Stratton, M. R. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proceedings of the National Academy of Sciences. 2008, 105 (35): 13081–13086. Bibcode:2008PNAS..10513081C. PMC 2529122 . PMID 18723673. doi:10.1073/pnas.0801523105 .
- Shipitsin, M; Campbell, L. L.; Argani, P; Weremowicz, S; Bloushtain-Qimron, N; Yao, J; Nikolskaya, T; Serebryiskaya, T; Beroukhim, R; Hu, M; Halushka, M. K.; Sukumar, S; Parker, L. M.; Anderson, K. S.; Harris, L. N.; Garber, J. E.; Richardson, A. L.; Schnitt, S. J.; Nikolsky, Y; Gelman, R. S.; Polyak, K. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11 (3): 259–273. PMID 17349583. doi:10.1016/j.ccr.2007.01.013 .
- Alvarado, C; Beitel, L. K.; Sircar, K; Aprikian, A; Trifiro, M; Gottlieb, B. Somatic mosaicism and cancer: A micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Research. 2005, 65 (18): 8514–8518. PMID 16166332. doi:10.1158/0008-5472.CAN-05-0399 .
- González-García, I; Solé, R. V.; Costa, J. Metapopulation dynamics and spatial heterogeneity in cancer. Proceedings of the National Academy of Sciences. 2002, 99 (20): 13085–13089. Bibcode:2002PNAS...9913085G. PMC 130590 . PMID 12351679. doi:10.1073/pnas.202139299 .
- Samowitz, W. S.; Slattery, M. L. Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes, Chromosomes and Cancer. 1999, 26 (2): 106–114. PMID 10469448. S2CID 5643190. doi:10.1002/(SICI)1098-2264(199910)26:2<106::AID-GCC2>3.0.CO;2-F.
- Maley, C. C.; Galipeau, P. C.; Finley, J. C.; Wongsurawat, V. J.; Li, X; Sanchez, C. A.; Paulson, T. G.; Blount, P. L.; Risques, R. A.; Rabinovitch, P. S.; Reid, B. J. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics. 2006, 38 (4): 468–473. PMID 16565718. S2CID 1898396. doi:10.1038/ng1768.
- Sauter, G; Moch, H; Gasser, T. C.; Mihatsch, M. J.; Waldman, F. M. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry. 1995, 21 (1): 40–46. PMID 8529469. doi:10.1002/cyto.990210109 .
- Horvai, A. E.; Devries, S; Roy, R; O'Donnell, R. J.; Waldman, F. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Modern Pathology. 2009, 22 (11): 1477–1488. PMID 19734852. doi:10.1038/modpathol.2009.119 .
- Pantou, D; Rizou, H; Tsarouha, H; Pouli, A; Papanastasiou, K; Stamatellou, M; Trangas, T; Pandis, N; Bardi, G. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes, Chromosomes and Cancer. 2005, 42 (1): 44–57. PMID 15495197. S2CID 43218546. doi:10.1002/gcc.20114.
- Shackleton, M; Quintana, E; Fearon, E. R.; Morrison, S. J. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell. 2009, 138 (5): 822–829. PMID 19737509. doi:10.1016/j.cell.2009.08.017 .
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- Swanton, C. Intratumor heterogeneity: Evolution through space and time. Cancer Research. 2012, 72 (19): 4875–4882. PMC 3712191 . PMID 23002210. doi:10.1158/0008-5472.CAN-12-2217.
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- Shackleton, M; Quintana, E; Fearon, E. R.; Morrison, S. J. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell. 2009, 138 (5): 822–829. PMID 19737509. doi:10.1016/j.cell.2009.08.017 .
- Lapidot, T; Sirard, C; Vormoor, J; Murdoch, B; Hoang, T; Caceres-Cortes, J; Minden, M; Paterson, B; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367 (6464): 645–648. Bibcode:1994Natur.367..645L. PMID 7509044. S2CID 4330788. doi:10.1038/367645a0.
- Wang, J. C.; Lapidot, T; Cashman, J. D.; Doedens, M; Addy, L; Sutherland, D. R.; Nayar, R; Laraya, P; Minden, M; Keating, A; Eaves, A. C. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood. 1998, 91 (7): 2406–2414. PMID 9516140. doi:10.1182/blood.V91.7.2406 .
- Singh, S. K.; Hawkins, C; Clarke, I. D.; Squire, J. A.; Bayani, J; Hide, T; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015): 396–401. Bibcode:2004Natur.432..396S. PMID 15549107. S2CID 4430962. doi:10.1038/nature03128.
- Al-Hajj, M; Wicha, M. S.; Benito-Hernandez, A; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences. 2003, 100 (7): 3983–3988. Bibcode:2003PNAS..100.3983A. PMC 153034 . PMID 12629218. doi:10.1073/pnas.0530291100 .
- Maitland, N. J.; Collins, A. T. Prostate cancer stem cells: A new target for therapy. Journal of Clinical Oncology. 2008, 26 (17): 2862–2870. PMID 18539965. doi:10.1200/JCO.2007.15.1472.
- Meacham, C. E.; Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature. 2013, 501 (7467): 328–337. Bibcode:2013Natur.501..328M. PMC 4521623 . PMID 24048065. doi:10.1038/nature12624.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Burrell, R. A.; McGranahan, N; Bartek, J; Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013, 501 (7467): 338–345. Bibcode:2013Natur.501..338B. PMID 24048066. S2CID 4457392. doi:10.1038/nature12625.
- Johnson, B. E.; Mazor, T; Hong, C; Barnes, M; Aihara, K; McLean, C. Y.; Fouse, S. D.; Yamamoto, S; Ueda, H; Tatsuno, K; Asthana, S; Jalbert, L. E.; Nelson, S. J.; Bollen, A. W.; Gustafson, W. C.; Charron, E; Weiss, W. A.; Smirnov, I. V.; Song, J. S.; Olshen, A. B.; Cha, S; Zhao, Y; Moore, R. A.; Mungall, A. J.; Jones, S. J.; Hirst, M; Marra, M. A.; Saito, N; Aburatani, H; Mukasa, A. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014, 343 (6167): 189–193. Bibcode:2014Sci...343..189J. PMC 3998672 . PMID 24336570. doi:10.1126/science.1239947.
- Ding, L; Ley, T. J.; Larson, D. E.; Miller, C. A.; Koboldt, D. C.; Welch, J. S.; Ritchey, J. K.; Young, M. A.; Lamprecht, T; McLellan, M. D.; McMichael, J. F.; Wallis, J. W.; Lu, C; Shen, D; Harris, C. C.; Dooling, D. J.; Fulton, R. S.; Fulton, L. L.; Chen, K; Schmidt, H; Kalicki-Veizer, J; Magrini, V. J.; Cook, L; McGrath, S. D.; Vickery, T. L.; Wendl, M. C.; Heath, S; Watson, M. A.; Link, D. C.; Tomasson, M. H. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012, 481 (7382): 506–510. Bibcode:2012Natur.481..506D. PMC 3267864 . PMID 22237025. doi:10.1038/nature10738.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- G.M.Edelman. Topobiology. Scientific American. 1989, 260 (5): 76–88. Bibcode:1989SciAm.260e..76E. PMID 2717916. doi:10.1038/scientificamerican0589-76.
- V.E. Orel; N.N Dzyatkovskaya; M.I. Danko; A.V. Romanov; Y.I. Mel'nik; Y.A. Grinevich; S.V. Martynenko. Spatial and mechanoemission chaos of mechanically deformed tumor cells. Journal of Mechanics in Medicine and Biology. 2004, 4 (1): 31–45 [2024-05-02]. doi:10.1142/s0219519404000886. （原始内容存档于2020-04-26）.
- V.E. Orel; A.V. Romanov; N.N. Dzyatkovskaya; Yu.I. Mel’nik. The device and algorithm for estimation of the mechanoemisson chaos in blood of patients with gastric cancer. Medical Engineering & Physics. 2002, 24 (5): 365–371 [2024-05-02]. PMID 12052364. doi:10.1016/s1350-4533(02)00022-x. （原始内容存档于2020-05-11）.
- N. Khranovskaya; V. Orel; Y. Grinevich; O. Alekseenko; A. Romanov; O. Skachkova; N.Dzyatkovskaya; A. Burlaka; S.Lukin. Mechanical heterogenization of Lewis lung carcinoma cells can improve antimetastatic effect of dendritic cells. Journal of Mechanics in Medicine and Biology. 2012, 3 (12): 22. doi:10.1142/S0219519411004757.
- Junttila, M. R.; De Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013, 501 (7467): 346–354. Bibcode:2013Natur.501..346J. PMID 24048067. S2CID 4452486. doi:10.1038/nature12626.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Auman, James Todd; McLeod, Howard L. Colorectal Cancer Cell Lines Lack the Molecular Heterogeneity of Clinical Colorectal Tumors. Clinical Colorectal Cancer. 2010-01-01, 9 (1): 40–47. PMID 20100687. doi:10.3816/ccc.2010.n.005.
- Cassidy, John W.; Caldas, Carlos; Bruna, Alejandra. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts. Cancer Research. 2015-08-01, 75 (15): 2963–2968. ISSN 0008-5472. PMC 4539570 . PMID 26180079. doi:10.1158/0008-5472.CAN-15-0727.
genepattern.org
- GenePattern. www.genepattern.org. [2024-05-02]. （原始内容存档于2024-05-02）.
harvard.edu
ui.adsabs.harvard.edu
- Vogelstein, Bert; Papadopoulos, N.; Velculescu, V.E.; Zhou, S.; Diaz, L.A.; Kinzler, K.W. Cancer Genome Landscapes. Science. 2013, 373 (6127): 1546–1556. Bibcode:2013Sci...339.1546V. PMC 3749880 . PMID 23539594. doi:10.1126/science.1235122.
- Reiter, Johannes G; Makohon-Moore, Alvin P; Gerold, Jeffrey M; Heyde, Alexander; Attiyeh, Marc A; Kohutek, Zachary A; Tokheim, Collin J; Brown, Alexia; DeBlasio, Rayne; Niyazov, Juliana; Zucker, Amanda. Minimal functional driver gene heterogeneity among untreated metastases. Science. 2018, 361 (6406): 1033–1037. Bibcode:2018Sci...361.1033R. PMC 6329287 . PMID 30190408. doi:10.1126/science.aat7171.
- Campbell, P. J.; Pleasance, E. D.; Stephens, P. J.; Dicks, E; Rance, R; Goodhead, I; Follows, G. A.; Green, A. R.; Futreal, P. A.; Stratton, M. R. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proceedings of the National Academy of Sciences. 2008, 105 (35): 13081–13086. Bibcode:2008PNAS..10513081C. PMC 2529122 . PMID 18723673. doi:10.1073/pnas.0801523105 .
- González-García, I; Solé, R. V.; Costa, J. Metapopulation dynamics and spatial heterogeneity in cancer. Proceedings of the National Academy of Sciences. 2002, 99 (20): 13085–13089. Bibcode:2002PNAS...9913085G. PMC 130590 . PMID 12351679. doi:10.1073/pnas.202139299 .
- Lapidot, T; Sirard, C; Vormoor, J; Murdoch, B; Hoang, T; Caceres-Cortes, J; Minden, M; Paterson, B; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367 (6464): 645–648. Bibcode:1994Natur.367..645L. PMID 7509044. S2CID 4330788. doi:10.1038/367645a0.
- Singh, S. K.; Hawkins, C; Clarke, I. D.; Squire, J. A.; Bayani, J; Hide, T; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015): 396–401. Bibcode:2004Natur.432..396S. PMID 15549107. S2CID 4430962. doi:10.1038/nature03128.
- Al-Hajj, M; Wicha, M. S.; Benito-Hernandez, A; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences. 2003, 100 (7): 3983–3988. Bibcode:2003PNAS..100.3983A. PMC 153034 . PMID 12629218. doi:10.1073/pnas.0530291100 .
- Meacham, C. E.; Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature. 2013, 501 (7467): 328–337. Bibcode:2013Natur.501..328M. PMC 4521623 . PMID 24048065. doi:10.1038/nature12624.
- Burrell, R. A.; McGranahan, N; Bartek, J; Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013, 501 (7467): 338–345. Bibcode:2013Natur.501..338B. PMID 24048066. S2CID 4457392. doi:10.1038/nature12625.
- Johnson, B. E.; Mazor, T; Hong, C; Barnes, M; Aihara, K; McLean, C. Y.; Fouse, S. D.; Yamamoto, S; Ueda, H; Tatsuno, K; Asthana, S; Jalbert, L. E.; Nelson, S. J.; Bollen, A. W.; Gustafson, W. C.; Charron, E; Weiss, W. A.; Smirnov, I. V.; Song, J. S.; Olshen, A. B.; Cha, S; Zhao, Y; Moore, R. A.; Mungall, A. J.; Jones, S. J.; Hirst, M; Marra, M. A.; Saito, N; Aburatani, H; Mukasa, A. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014, 343 (6167): 189–193. Bibcode:2014Sci...343..189J. PMC 3998672 . PMID 24336570. doi:10.1126/science.1239947.
- Ding, L; Ley, T. J.; Larson, D. E.; Miller, C. A.; Koboldt, D. C.; Welch, J. S.; Ritchey, J. K.; Young, M. A.; Lamprecht, T; McLellan, M. D.; McMichael, J. F.; Wallis, J. W.; Lu, C; Shen, D; Harris, C. C.; Dooling, D. J.; Fulton, R. S.; Fulton, L. L.; Chen, K; Schmidt, H; Kalicki-Veizer, J; Magrini, V. J.; Cook, L; McGrath, S. D.; Vickery, T. L.; Wendl, M. C.; Heath, S; Watson, M. A.; Link, D. C.; Tomasson, M. H. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012, 481 (7382): 506–510. Bibcode:2012Natur.481..506D. PMC 3267864 . PMID 22237025. doi:10.1038/nature10738.
- G.M.Edelman. Topobiology. Scientific American. 1989, 260 (5): 76–88. Bibcode:1989SciAm.260e..76E. PMID 2717916. doi:10.1038/scientificamerican0589-76.
- Junttila, M. R.; De Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013, 501 (7467): 346–354. Bibcode:2013Natur.501..346J. PMID 24048067. S2CID 4452486. doi:10.1038/nature12626.
nih.gov
ncbi.nlm.nih.gov
- Marusyk, A; Polyak, K. Tumor heterogeneity: Causes and consequences. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2010, 1805 (1): 105–117. PMC 2814927 . PMID 19931353. doi:10.1016/j.bbcan.2009.11.002.
- Vogelstein, Bert; Papadopoulos, N.; Velculescu, V.E.; Zhou, S.; Diaz, L.A.; Kinzler, K.W. Cancer Genome Landscapes. Science. 2013, 373 (6127): 1546–1556. Bibcode:2013Sci...339.1546V. PMC 3749880 . PMID 23539594. doi:10.1126/science.1235122.
- Heppner, G.A. Tumor Heterogeneity. Cancer Research. 1984, 44 (6): 2259–2265. PMID 6372991.
- Reiter, Johannes G; Makohon-Moore, Alvin P; Gerold, Jeffrey M; Heyde, Alexander; Attiyeh, Marc A; Kohutek, Zachary A; Tokheim, Collin J; Brown, Alexia; DeBlasio, Rayne; Niyazov, Juliana; Zucker, Amanda. Minimal functional driver gene heterogeneity among untreated metastases. Science. 2018, 361 (6406): 1033–1037. Bibcode:2018Sci...361.1033R. PMC 6329287 . PMID 30190408. doi:10.1126/science.aat7171.
- Campbell, P. J.; Pleasance, E. D.; Stephens, P. J.; Dicks, E; Rance, R; Goodhead, I; Follows, G. A.; Green, A. R.; Futreal, P. A.; Stratton, M. R. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proceedings of the National Academy of Sciences. 2008, 105 (35): 13081–13086. Bibcode:2008PNAS..10513081C. PMC 2529122 . PMID 18723673. doi:10.1073/pnas.0801523105 .
- Shipitsin, M; Campbell, L. L.; Argani, P; Weremowicz, S; Bloushtain-Qimron, N; Yao, J; Nikolskaya, T; Serebryiskaya, T; Beroukhim, R; Hu, M; Halushka, M. K.; Sukumar, S; Parker, L. M.; Anderson, K. S.; Harris, L. N.; Garber, J. E.; Richardson, A. L.; Schnitt, S. J.; Nikolsky, Y; Gelman, R. S.; Polyak, K. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11 (3): 259–273. PMID 17349583. doi:10.1016/j.ccr.2007.01.013 .
- MacIntosh, C. A.; Stower, M; Reid, N; Maitland, N. J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Research. 1998, 58 (1): 23–28. PMID 9426051.
- Alvarado, C; Beitel, L. K.; Sircar, K; Aprikian, A; Trifiro, M; Gottlieb, B. Somatic mosaicism and cancer: A micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Research. 2005, 65 (18): 8514–8518. PMID 16166332. doi:10.1158/0008-5472.CAN-05-0399 .
- Konishi, N; Hiasa, Y; Matsuda, H; Tao, M; Tsuzuki, T; Hayashi, I; Kitahori, Y; Shiraishi, T; Yatani, R; Shimazaki, J. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. The American Journal of Pathology. 1995, 147 (4): 1112–1122. PMC 1871010 . PMID 7573356.
- González-García, I; Solé, R. V.; Costa, J. Metapopulation dynamics and spatial heterogeneity in cancer. Proceedings of the National Academy of Sciences. 2002, 99 (20): 13085–13089. Bibcode:2002PNAS...9913085G. PMC 130590 . PMID 12351679. doi:10.1073/pnas.202139299 .
- Samowitz, W. S.; Slattery, M. L. Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes, Chromosomes and Cancer. 1999, 26 (2): 106–114. PMID 10469448. S2CID 5643190. doi:10.1002/(SICI)1098-2264(199910)26:2<106::AID-GCC2>3.0.CO;2-F.
- Giaretti, W; Monaco, R; Pujic, N; Rapallo, A; Nigro, S; Geido, E. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: Association with degree of DNA aneuploidy. The American Journal of Pathology. 1996, 149 (1): 237–245. PMC 1865212 . PMID 8686748.
- Heppner, G. H. Tumor heterogeneity. Cancer Research. 1984, 44 (6): 2259–2265. PMID 6372991.
- Maley, C. C.; Galipeau, P. C.; Finley, J. C.; Wongsurawat, V. J.; Li, X; Sanchez, C. A.; Paulson, T. G.; Blount, P. L.; Risques, R. A.; Rabinovitch, P. S.; Reid, B. J. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics. 2006, 38 (4): 468–473. PMID 16565718. S2CID 1898396. doi:10.1038/ng1768.
- Califano, J; Van Der Riet, P; Westra, W; Nawroz, H; Clayman, G; Piantadosi, S; Corio, R; Lee, D; Greenberg, B; Koch, W; Sidransky, D. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Research. 1996, 56 (11): 2488–2492. PMID 8653682.
- Sauter, G; Moch, H; Gasser, T. C.; Mihatsch, M. J.; Waldman, F. M. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry. 1995, 21 (1): 40–46. PMID 8529469. doi:10.1002/cyto.990210109 .
- Fujii, H; Yoshida, M; Gong, Z. X.; Matsumoto, T; Hamano, Y; Fukunaga, M; Hruban, R. H.; Gabrielson, E; Shirai, T. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Research. 2000, 60 (1): 114–120. PMID 10646862.
- Horvai, A. E.; Devries, S; Roy, R; O'Donnell, R. J.; Waldman, F. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Modern Pathology. 2009, 22 (11): 1477–1488. PMID 19734852. doi:10.1038/modpathol.2009.119 .
- Pantou, D; Rizou, H; Tsarouha, H; Pouli, A; Papanastasiou, K; Stamatellou, M; Trangas, T; Pandis, N; Bardi, G. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes, Chromosomes and Cancer. 2005, 42 (1): 44–57. PMID 15495197. S2CID 43218546. doi:10.1002/gcc.20114.
- Shackleton, M; Quintana, E; Fearon, E. R.; Morrison, S. J. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell. 2009, 138 (5): 822–829. PMID 19737509. doi:10.1016/j.cell.2009.08.017 .
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- Swanton, C. Intratumor heterogeneity: Evolution through space and time. Cancer Research. 2012, 72 (19): 4875–4882. PMC 3712191 . PMID 23002210. doi:10.1158/0008-5472.CAN-12-2217.
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- Shackleton, M; Quintana, E; Fearon, E. R.; Morrison, S. J. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell. 2009, 138 (5): 822–829. PMID 19737509. doi:10.1016/j.cell.2009.08.017 .
- Lapidot, T; Sirard, C; Vormoor, J; Murdoch, B; Hoang, T; Caceres-Cortes, J; Minden, M; Paterson, B; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367 (6464): 645–648. Bibcode:1994Natur.367..645L. PMID 7509044. S2CID 4330788. doi:10.1038/367645a0.
- Wang, J. C.; Lapidot, T; Cashman, J. D.; Doedens, M; Addy, L; Sutherland, D. R.; Nayar, R; Laraya, P; Minden, M; Keating, A; Eaves, A. C. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood. 1998, 91 (7): 2406–2414. PMID 9516140. doi:10.1182/blood.V91.7.2406 .
- Singh, S. K.; Hawkins, C; Clarke, I. D.; Squire, J. A.; Bayani, J; Hide, T; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015): 396–401. Bibcode:2004Natur.432..396S. PMID 15549107. S2CID 4430962. doi:10.1038/nature03128.
- Al-Hajj, M; Wicha, M. S.; Benito-Hernandez, A; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences. 2003, 100 (7): 3983–3988. Bibcode:2003PNAS..100.3983A. PMC 153034 . PMID 12629218. doi:10.1073/pnas.0530291100 .
- Maitland, N. J.; Collins, A. T. Prostate cancer stem cells: A new target for therapy. Journal of Clinical Oncology. 2008, 26 (17): 2862–2870. PMID 18539965. doi:10.1200/JCO.2007.15.1472.
- Meacham, C. E.; Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature. 2013, 501 (7467): 328–337. Bibcode:2013Natur.501..328M. PMC 4521623 . PMID 24048065. doi:10.1038/nature12624.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Burrell, R. A.; McGranahan, N; Bartek, J; Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013, 501 (7467): 338–345. Bibcode:2013Natur.501..338B. PMID 24048066. S2CID 4457392. doi:10.1038/nature12625.
- Johnson, B. E.; Mazor, T; Hong, C; Barnes, M; Aihara, K; McLean, C. Y.; Fouse, S. D.; Yamamoto, S; Ueda, H; Tatsuno, K; Asthana, S; Jalbert, L. E.; Nelson, S. J.; Bollen, A. W.; Gustafson, W. C.; Charron, E; Weiss, W. A.; Smirnov, I. V.; Song, J. S.; Olshen, A. B.; Cha, S; Zhao, Y; Moore, R. A.; Mungall, A. J.; Jones, S. J.; Hirst, M; Marra, M. A.; Saito, N; Aburatani, H; Mukasa, A. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014, 343 (6167): 189–193. Bibcode:2014Sci...343..189J. PMC 3998672 . PMID 24336570. doi:10.1126/science.1239947.
- Ding, L; Ley, T. J.; Larson, D. E.; Miller, C. A.; Koboldt, D. C.; Welch, J. S.; Ritchey, J. K.; Young, M. A.; Lamprecht, T; McLellan, M. D.; McMichael, J. F.; Wallis, J. W.; Lu, C; Shen, D; Harris, C. C.; Dooling, D. J.; Fulton, R. S.; Fulton, L. L.; Chen, K; Schmidt, H; Kalicki-Veizer, J; Magrini, V. J.; Cook, L; McGrath, S. D.; Vickery, T. L.; Wendl, M. C.; Heath, S; Watson, M. A.; Link, D. C.; Tomasson, M. H. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012, 481 (7382): 506–510. Bibcode:2012Natur.481..506D. PMC 3267864 . PMID 22237025. doi:10.1038/nature10738.
- MutaGene: Explore and analyze context-dependent mutational signatures in cancer - Home page. www.ncbi.nlm.nih.gov. [2024-05-02]. （原始内容存档于2023-03-18）.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Gerlinger, M; Rowan, A. J.; Horswell, S; Larkin, J; Endesfelder, D; Gronroos, E; Martinez, P; Matthews, N; Stewart, A; Tarpey, P; Varela, I; Phillimore, B; Begum, S; McDonald, N. Q.; Butler, A; Jones, D; Raine, K; Latimer, C; Santos, C. R.; Nohadani, M; Eklund, A. C.; Spencer-Dene, B; Clark, G; Pickering, L; Stamp, G; Gore, M; Szallasi, Z; Downward, J; Futreal, P. A.; Swanton, C. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine. 2012, 366 (10): 883–892. PMC 4878653 . PMID 22397650. doi:10.1056/NEJMoa1113205.
- G.M.Edelman. Topobiology. Scientific American. 1989, 260 (5): 76–88. Bibcode:1989SciAm.260e..76E. PMID 2717916. doi:10.1038/scientificamerican0589-76.
- V.E. Orel; A.V. Romanov; N.N. Dzyatkovskaya; Yu.I. Mel’nik. The device and algorithm for estimation of the mechanoemisson chaos in blood of patients with gastric cancer. Medical Engineering & Physics. 2002, 24 (5): 365–371 [2024-05-02]. PMID 12052364. doi:10.1016/s1350-4533(02)00022-x. （原始内容存档于2020-05-11）.
- Junttila, M. R.; De Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013, 501 (7467): 346–354. Bibcode:2013Natur.501..346J. PMID 24048067. S2CID 4452486. doi:10.1038/nature12626.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Auman, James Todd; McLeod, Howard L. Colorectal Cancer Cell Lines Lack the Molecular Heterogeneity of Clinical Colorectal Tumors. Clinical Colorectal Cancer. 2010-01-01, 9 (1): 40–47. PMID 20100687. doi:10.3816/ccc.2010.n.005.
- Cassidy, John W.; Caldas, Carlos; Bruna, Alejandra. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts. Cancer Research. 2015-08-01, 75 (15): 2963–2968. ISSN 0008-5472. PMC 4539570 . PMID 26180079. doi:10.1158/0008-5472.CAN-15-0727.
researchgate.net
- V.E. Orel; N.N Dzyatkovskaya; M.I. Danko; A.V. Romanov; Y.I. Mel'nik; Y.A. Grinevich; S.V. Martynenko. Spatial and mechanoemission chaos of mechanically deformed tumor cells. Journal of Mechanics in Medicine and Biology. 2004, 4 (1): 31–45 [2024-05-02]. doi:10.1142/s0219519404000886. （原始内容存档于2020-04-26）.
- V.E. Orel; A.V. Romanov; N.N. Dzyatkovskaya; Yu.I. Mel’nik. The device and algorithm for estimation of the mechanoemisson chaos in blood of patients with gastric cancer. Medical Engineering & Physics. 2002, 24 (5): 365–371 [2024-05-02]. PMID 12052364. doi:10.1016/s1350-4533(02)00022-x. （原始内容存档于2020-05-11）.
sanger.ac.uk
cancer.sanger.ac.uk
- COSMIC | Mutational Signatures. cancer.sanger.ac.uk. [2024-05-02]. （原始内容存档于2024-09-30）.
semanticscholar.org
api.semanticscholar.org
- Samowitz, W. S.; Slattery, M. L. Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes, Chromosomes and Cancer. 1999, 26 (2): 106–114. PMID 10469448. S2CID 5643190. doi:10.1002/(SICI)1098-2264(199910)26:2<106::AID-GCC2>3.0.CO;2-F.
- Maley, C. C.; Galipeau, P. C.; Finley, J. C.; Wongsurawat, V. J.; Li, X; Sanchez, C. A.; Paulson, T. G.; Blount, P. L.; Risques, R. A.; Rabinovitch, P. S.; Reid, B. J. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nature Genetics. 2006, 38 (4): 468–473. PMID 16565718. S2CID 1898396. doi:10.1038/ng1768.
- Pantou, D; Rizou, H; Tsarouha, H; Pouli, A; Papanastasiou, K; Stamatellou, M; Trangas, T; Pandis, N; Bardi, G. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes, Chromosomes and Cancer. 2005, 42 (1): 44–57. PMID 15495197. S2CID 43218546. doi:10.1002/gcc.20114.
- Lapidot, T; Sirard, C; Vormoor, J; Murdoch, B; Hoang, T; Caceres-Cortes, J; Minden, M; Paterson, B; Caligiuri, M. A.; Dick, J. E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994, 367 (6464): 645–648. Bibcode:1994Natur.367..645L. PMID 7509044. S2CID 4330788. doi:10.1038/367645a0.
- Singh, S. K.; Hawkins, C; Clarke, I. D.; Squire, J. A.; Bayani, J; Hide, T; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature. 2004, 432 (7015): 396–401. Bibcode:2004Natur.432..396S. PMID 15549107. S2CID 4430962. doi:10.1038/nature03128.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Burrell, R. A.; McGranahan, N; Bartek, J; Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013, 501 (7467): 338–345. Bibcode:2013Natur.501..338B. PMID 24048066. S2CID 4457392. doi:10.1038/nature12625.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
- Junttila, M. R.; De Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013, 501 (7467): 346–354. Bibcode:2013Natur.501..346J. PMID 24048067. S2CID 4452486. doi:10.1038/nature12626.
- Marusyk, A; Almendro, V; Polyak, K. Intra-tumour heterogeneity: A looking glass for cancer?. Nature Reviews Cancer. 2012, 12 (5): 323–334. PMID 22513401. S2CID 24420285. doi:10.1038/nrc3261.
web.archive.org
- GenePattern. www.genepattern.org. [2024-05-02]. （原始内容存档于2024-05-02）.
- COSMIC | Mutational Signatures. cancer.sanger.ac.uk. [2024-05-02]. （原始内容存档于2024-09-30）.
- MutaGene: Explore and analyze context-dependent mutational signatures in cancer - Home page. www.ncbi.nlm.nih.gov. [2024-05-02]. （原始内容存档于2023-03-18）.
- V.E. Orel; N.N Dzyatkovskaya; M.I. Danko; A.V. Romanov; Y.I. Mel'nik; Y.A. Grinevich; S.V. Martynenko. Spatial and mechanoemission chaos of mechanically deformed tumor cells. Journal of Mechanics in Medicine and Biology. 2004, 4 (1): 31–45 [2024-05-02]. doi:10.1142/s0219519404000886. （原始内容存档于2020-04-26）.
- V.E. Orel; A.V. Romanov; N.N. Dzyatkovskaya; Yu.I. Mel’nik. The device and algorithm for estimation of the mechanoemisson chaos in blood of patients with gastric cancer. Medical Engineering & Physics. 2002, 24 (5): 365–371 [2024-05-02]. PMID 12052364. doi:10.1016/s1350-4533(02)00022-x. （原始内容存档于2020-05-11）.
worldcat.org
- Cassidy, John W.; Caldas, Carlos; Bruna, Alejandra. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts. Cancer Research. 2015-08-01, 75 (15): 2963–2968. ISSN 0008-5472. PMC 4539570 . PMID 26180079. doi:10.1158/0008-5472.CAN-15-0727.